PainChek Limited
PainChek Limited (PCK.AX) Stock Overview
Explore PainChek Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
77.4M
P/E Ratio
-8.48
EPS (TTM)
$-0.01
ROE
-4.53%
PCK.AX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of PainChek Limited (PCK.AX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.03.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -8.48 and a market capitalization of 77.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
PainChek Limited develops and commercializes mobile medical device applications that provides pain assessment for individuals. The company offers PainChek, which uses camera in smartphones and tablets to capture video that is analyzed in real time using facial recognition software to indicate the presence of the pain. It serves patients suffering with dementia. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited in January 2018. PainChek Limited is based in Sydney, Australia.
Philip Daffas Dip EENG, GAICD,
35 Lime Street, Sydney, NSW
2012